Centessa Pharmaceuticals
Sai Pulukuri has extensive work experience in the field of immunooncology, pharmacology, and translational science. Starting in 2000, Pulukuri worked as a Research Manager at Biological E. LTD before moving on to various research and leadership roles at organizations such as Indian Institute of Science, University of Illinois, Purdue University, and Kylin Therapeutics. Pulukuri also held positions at Takeda Oncology, FORMA Therapeutics, AstraZeneca, Astellas Pharma, and currently serves as Vice President at Centessa Pharmaceuticals. Pulukuri's responsibilities have included leading drug discovery and development programs, designing and executing preclinical and clinical studies, identifying novel targets, and managing industry partnerships and alliances.
Sai Pulukuri holds a Ph.D in Microbiology from Osmania University. Prior to that, Pulukuri obtained an MSc in Microbiology and Immunology from Acharya Nagarjuna University and a BSc in Biology, also from Acharya Nagarjuna University.
This person is not in the org chart
Centessa Pharmaceuticals
1 followers
Centessa Pharmaceuticals Limited is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams. Each program is developed by an Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.